TOPLINE: A Danish study found that replacing the conventional fluorine-18 sodium fluoride (18F-NaF) PET/CT ("NaF" scan for short) with fluorine-18 prostate-specific membrane antigen-1007 (18F-PSMA) PET/CT ("PSMA" scan for short) for the staging of high-risk prostate cancer resulted in significant metastatic stage migration and the alteration of treatment plans in a significant number of patients, thereby
Now that most of the US (and the world) is under quarantine, communication has largely shifted to live stream video services like Skype, FaceTime, and Zoom. And while it’s easy to initiate or join a live video stream while working from home, with just a little effort, you can make the quality of your WFH…
Now that most of the US (and the world) is under quarantine, communication has largely shifted to live stream video services like Skype, FaceTime, and Zoom. And while it’s easy to initiate or join a live video stream while working from home, with just a little effort, you can make the quality of your WFH…
Now that most of the US (and the world) is under quarantine, communication has largely shifted to live stream video services like Skype, FaceTime, and Zoom. And while it’s easy to initiate or join a live video stream while working from home, with just a little effort, you can make the quality of your WFH…
Robert F. Kennedy Jr. has rightly made “radical transparency” the motto of his Department of Health and Human Services. HHS even has a page by that name. I think it is a good motto, and I want to help Secretary Kennedy and Acting FDA Commissioner Kyle Diamantas deliver on it in food safety, with two citizen petitions
Published: October 30, 2026, 10:16 pm Several reports of children choking have led to an FDA warning against Once Upon A Time snacks. The warning covers all flavors, quantities, lots and dates of Once Upon A Farm Tractor Wheels Organic, Toddler Soft-Baked Bars. The FDA has received several reports that describe infants ages 1.5 to
The FDA has cleared the interleukin (IL)-23 inhibitor tildrakizumab (Ilumya) for the treatment of active psoriatic arthritis (PsA) in adults. Sun Pharma announced the approval on October 30. “As an IL-23 inhibitor administered exclusively by a healthcare provider, Ilumya is now an option for adults with active psoriatic arthritis who are unable to self-administer treatment